TerminatedEUCTR 2016-000215-32

Effect of Pycnogenol® on Attention-Deficit Hyperactivity Disorder (ADHD): A randomized, double blind, placebo and active product controlled multicenter trial.

This historical record does not confirm current site availability.

Historical research recordBelgium

The study in practice

Understand this study

What is this study about?

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.

Listed locations: Belgium
Study phase: Phase 3

Get this study by email

What to know before participating

A point to clarify

This is historical registry information. What is the current study status and protocol?

Study clarity

Things to check before joining

Study start dateNot clearly listed

Recruitment status: Terminated
Enrollment listed in the registry: Not clearly listed
Sponsor: University of Antwerp
Sponsor type: University
Study type: Biological
Intervention type: Biological, Drug
Study phase: Phase 3
Locations: Belgium
Age range: Not clearly listed
Official registry ID: EUCTR 2016-000215-32
Official title: Show the full official title
Effect of Pycnogenol® on Attention-Deficit Hyperactivity Disorder (ADHD): A randomized, double blind, placebo and active product controlled multicenter trial.

Recruitment & locations

Terminated

Belgium

Registry details

Historical country statuses

Belgium — Prematurely Ended

Interested in joining this study?

FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Antwerp, a university.

Is this study still recruiting?

The historical registry lists this study as terminated.

Want to explore more studies?

Explore studies